The goal of this clinical trial is to learn if a psychomotor (a body-oriented therapy) group intervention can be feasibly delivered to a group of young adults (age 18-35) with anxiety symptoms within a higher educational setting. The main questions it aims to answer are: * Is it possible to recruit and retain participants in this intervention? * Is the intervention acceptable and tolerable to participants? * Do participants complete the planned sessions and assessments? Participants will: * Attend one weekly group session over ten consecutive weeks * Participate in active and contemplative body-based exercises * Complete questionnaires about their mental health and interviews about their experiences of participating
Age range
18 Years – 34 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of participants recruited
Timeframe: For each participant: 20 minutes during the three month enrollment period.
Number of participants retained
Timeframe: From enrollment to end of intervention at 11 weeks
Attendance
Timeframe: From beginning of intervention to end of intervention at 11 weeks
Acceptability to participants
Timeframe: Post intervention at 12 weeks
Fidelity of the intervention
Timeframe: From beginning of intervention to end of intervention at 11 weeks